nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
|
Merlano, Marco C. |
|
2018 |
12 |
C |
p. 47-52 |
artikel |
2 |
A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective observational study
|
Saito, Tetsuo |
|
2018 |
12 |
C |
p. 34-39 |
artikel |
3 |
A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?
|
Ng, Sweet Ping |
|
2018 |
12 |
C |
p. 40-46 |
artikel |
4 |
Four different treatment strategies in aggressive fibromatosis: A systematic review
|
Seinen, Jojanneke M. |
|
2018 |
12 |
C |
p. 1-7 |
artikel |
5 |
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic
|
Patrikidou, Anna |
|
2018 |
12 |
C |
p. 28-33 |
artikel |
6 |
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
|
Schernberg, Antoine |
|
2018 |
12 |
C |
p. 8-15 |
artikel |
7 |
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
|
Dillon, M.T. |
|
2018 |
12 |
C |
p. 16-20 |
artikel |
8 |
Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin
|
Ligtenberg, Hans |
|
2018 |
12 |
C |
p. 21-27 |
artikel |